271 related articles for article (PubMed ID: 18292241)
1. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.
Mukherjee A; Rotwein P
Mol Endocrinol; 2008 May; 22(5):1238-50. PubMed ID: 18292241
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions.
Mukherjee A; Wilson EM; Rotwein P
Mol Endocrinol; 2008 Jan; 22(1):206-15. PubMed ID: 17885206
[TBL] [Abstract][Full Text] [Related]
3. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding Protein-3 suppresses osteoblast differentiation via bone morphogenetic protein-2.
Eguchi K; Akiba Y; Akiba N; Nagasawa M; Cooper LF; Uoshima K
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):465-470. PubMed ID: 30454898
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures.
Gabbitas B; Canalis E
Endocrinology; 1995 Jun; 136(6):2397-403. PubMed ID: 7538461
[TBL] [Abstract][Full Text] [Related]
6. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
7. Evidence that IGF-binding protein-5 functions as a growth factor.
Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182
[TBL] [Abstract][Full Text] [Related]
8. Akt promotes BMP2-mediated osteoblast differentiation and bone development.
Mukherjee A; Rotwein P
J Cell Sci; 2009 Mar; 122(Pt 5):716-26. PubMed ID: 19208758
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts.
Govoni KE; Amaar YG; Kramer A; Winter E; Baylink DJ; Mohan S
Growth Horm IGF Res; 2006 Feb; 16(1):49-56. PubMed ID: 16311053
[TBL] [Abstract][Full Text] [Related]
10. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts.
Birnbaum RS; Wiren KM
Endocrinology; 1994 Jul; 135(1):223-30. PubMed ID: 8013356
[TBL] [Abstract][Full Text] [Related]
11. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast differentiation of NIH3T3 fibroblasts is associated with changes in the IGF-I/IGFBP expression pattern.
Abdallah BM
Cell Mol Biol Lett; 2006; 11(4):461-74. PubMed ID: 17001448
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
16. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.
Celil AB; Campbell PG
J Biol Chem; 2005 Sep; 280(36):31353-9. PubMed ID: 16000303
[TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.
Knutsen R; Honda Y; Strong DD; Sampath TK; Baylink DJ; Mohan S
Endocrinology; 1995 Mar; 136(3):857-65. PubMed ID: 7532581
[TBL] [Abstract][Full Text] [Related]
18. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
[TBL] [Abstract][Full Text] [Related]
19. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
[TBL] [Abstract][Full Text] [Related]
20. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
